STMN1 and breast carcinoma: The decrease of miR-101 promoted cell proliferation, migration and invasion, and inhibited cell apoptosis by targeting Stmn1. These results suggest that miR-101 may act as a tumor suppressor and can be a novel candidate gene for the diagnosis and therapy to different subtypes of breast cancer.